Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy denver denver botanic garden

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Psychedelics haven’t fulfilled clinical expectations, but new trial strategies could turn the tide - 12 days ago Despite adcomm rejection, Lykos CEO sees future for MDMA drug - 6 months ago
2	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	The world’s most mysterious psychedelic is already inside your brain - 14 days ago Nitrous, one of the oldest mind-altering drugs, is back - 3 months ago MDMA therapy didn’t get FDA approval. Now what? - 4 months ago Psychedelics are about to become a casualty of Oregon’s opioid crisis - 9 months ago Why psychedelics produce some of the most meaningful experiences in people’s lives - about 1 year ago Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - about 1 year ago
3	Carly Cassella Science Alert Writer at ScienceAlert. Sciencewriting	First Traces of Ancient Egyptian Hallucinogens Found in Old Jug - 23 days ago
4	Andrew Paul Popular Science Now on Bluesky America's Heartland Blueskywriting	Ancient Egyptian ritual potion included hallucinogens and bodily fluids - about 1 month ago
5	Kristen Monaco MedPage Today	Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions - about 1 month ago More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 4 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 4 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 10 months ago Psychedelics for Psych Conditions Made Their Mark in 2023 - 12 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago
6	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	What’s Next for Psychedelic Medicines? - about 2 months ago
7	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia - 4 months ago
8	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 4 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 4 months ago A tough week for MDMA-assisted psychotherapy - 4 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 4 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 4 months ago Psychedelic investment continues to ramp up - 10 months ago
9	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - 4 months ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - 4 months ago The Case for MDMA’s Approval Is Riddled With Problems - 7 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - 4 months ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - about 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - about 1 year ago

Journalists covering ecstasy